EpiCast Report: Supportive Care in Oncology - Epidemiology Forecast to 2026
SummaryCancer is a broad term for a group of diseases characterized by uncontrolled cell proliferation in any part of the body that may spread beyond the cells’ normal boundaries (WHO, 2017). Worldwide, it is estimated that around 14 million new cases of cancer are diagnosed each year, and 30-50% of those cases are preventable (WHO, 2017). Cancer is the second leading cause of death worldwide, with more than eight million deaths caused by cancer in 2015 (WHO, 2017). The etiology of cancer varies with each type; however, the most common risk factors include tobacco use, lack of physical exercise, unhealthy diet, and old age (WHO, 2017).
In 2016, there were more than 900,000 diagnosed incident cases of all cancer receiving chemotherapy treatment in men and women, ages 18 years and older, in the 7MM. Combination therapy was more common, with more than 75% of cases receiving chemotherapy in conjunction with surgery, radiation, or both. The remainder of about 24% casesreceived chemotherapy alone. Of those receiving chemotherapy, anemia and nausea and vomiting were the most common conditions resulting from the treatment. In 2016, there were more than 800,000 cases of chemotherapy-induced anemia and almost 750,000 cases of chemotherapy-induced nausea and vomiting in the 7MM.
In 2016, Spain had the highest age-standardized diagnosed incidence of all cancer in men at more than 570 cases per 100,000. Germany had the lowest age-standardized diagnosed incidence of all cancer in men at around 428 cases per 100,000.The US had an age-standardized diagnosed incidence of all cancer of about 435 cases per 100,000 in 2016. As far as womenare concerned, in 2016, the US had the highest age-standardized rate of over 400 cases per 100,000, while Japan had the lowest rate at around 325cases per 100,000. The UK had the highest age-standardized rate of around 400 cases per 100,000 out of the five European countries (5EU: France, Germany, Italy, Spain, and UK).
The report EpiCast Report: Supportive Care in Oncology - Epidemiology Forecast to 2026, provides an overview of the global and historical trends for all cancer in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of all cancer segmented by age (beginning at 18 years and ending at 80 years and older) and sex. It also provides the proportion of all cancer cases treated with chemotherapy and the number of those cases that develop a chemotherapy-induced condition.
Furthermore, this report provides the number of diagnosed incident cases of prostate (men ages 35 years and older), breast (women ages 20 years and older), and lung cancer (men and women ages 20 years and older), and the proportion of those that metastasize to bone. Finally, the report also provides a forecast of the five-year diagnosed prevalent cases of all cancer in men and women combined (ages 18 years and older).